Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CORDONNIER, C.
Right arrow Articles by CHATELLIER, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CORDONNIER, C.
Right arrow Articles by CHATELLIER, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology


research-article

DIAGNOSTIC VALUE OF ANTI-RA33 ANTIBODY, ANTIKERATIN ANTIBODY, ANTIPERINUCLEAR FACTOR AND ANTINUCLEAR ANTIBODY IN EARLY RHEUMATOID ARTHRITIS: COMPARISON WITH RHEUMATOID FACTOR

C. CORDONNIER, O. MEYER, E. PALAZZO, M. DE BANDT, A. ELIAS, P. NICAISE, T. HAÏM, M. F. KAHN and G. CHATELLIER*

Rheumatology Department, Centre Hospitalier Universitaire X Bichat, Paris
*Biostatistics Department Broussais Hospital, Paris, France

Correspondence to: Correspondence to: O. Meyer, Service de Rhumatologie, Centre Hospitalier Universitaire X. Bichat, 46 rue Henri Huchard, 75018 Paris, France.

The goal of this prospective longitudinal study was to determine the serological profile of early rheumatoid arthritis (RA), and to test whether antikeratin antibody (AKA), antiperinuclear factor (APF), anti-RA33 antibody and antinuclear antibodies (ANA) had an additional diagnostic value when prescribed after rheumatoid factor (RF)-detecting methods. Sixty-nine patients with early polyarthritis suggestive of RA, seen between 1991 and 1993, were included. Five autoantibodies (i.e. RF, AKA, APF, RA33, ANA) were looked for at regular intervals. After 24 months follow-up, patients were classified as having RA (n = 49), unclassified polyarthritis (UP; n = 15) or other rheumatic diseases. Among patients with early RA, the sensitivity of these markers was 40.8% for RF, 36.7% for AKA, 28.6% for APF and 28.6% for anti-RA33. Among RF-negative RA patients, 51.7% were positive for AKA, APF, anti-RA33 antibodies and/or ANA. Positivity of the three recent markers usually persisted throughout follow-up, whereas RF was lost by 58% of patients with early, RF-positive, treated RA. Using multivariate analysis, only latex, RF test and AKA or APF had an independent and statistically significant diagnostic value for early RA. Our data suggest that RF and AKA (or APF) should be concomitantly determined for diagnosis in patients with suspected early RA.

KEY WORDS: Early rheumatoid arthritis, Anti-RA33 antibody, Antikeratin antibody, Antiperinuclear factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
G Schett, H Dumortier, E Hoefler, S Muller, and G Steiner
B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease
Ann Rheum Dis, May 1, 2009; 68(5): 729 - 735.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. Nishimura, D. Sugiyama, Y. Kogata, G. Tsuji, T. Nakazawa, S. Kawano, K. Saigo, A. Morinobu, M. Koshiba, K. M. Kuntz, et al.
Meta-analysis: Diagnostic Accuracy of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
Ann Intern Med, June 5, 2007; 146(11): 797 - 808.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S Dubucquoi, E Solau-Gervais, D Lefranc, L Marguerie, J Sibilia, J Goetz, V Dutoit, A-L Fauchais, E Hachulla, R-M Flipo, et al.
Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases
Ann Rheum Dis, April 1, 2004; 63(4): 415 - 419.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
O Meyer, C Labarre, M Dougados, P. Goupille, A Cantagrel, A Dubois, P Nicaise-Roland, J Sibilia, and B Combe
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
Ann Rheum Dis, February 1, 2003; 62(2): 120 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Fritsch, D. Eselbock, K. Skriner, B. Jahn-Schmid, C. Scheinecker, B. Bohle, M. Tohidast-Akrad, S. Hayer, J. Neumuller, S. Pinol-Roma, et al.
Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis
J. Immunol., July 15, 2002; 169(2): 1068 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
L Paimela, T Palosuo, K Aho, M Lukka, P Kurki, M Leirisalo-Repo, and R von Essen
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis
Ann Rheum Dis, January 1, 2001; 60(1): 32 - 35.
[Abstract] [Full Text]


Home page
IOVSHome page
I. Reynolds, A. B. Tullo, S. L. John, P. J. L. Holt, and M. C. Hillarby
Corneal Epithelial-Specific Cytokeratin 3 is an Autoantigen in Wegener’s Granulomatosis-Associated Peripheral Ulcerative Keratitis
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2147 - 2151.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Hayem, M De Bandt, E Palazzo, S Roux, B Combe, J F Eliaou, J Sany, M F Kahn, and O Meyer
Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis
Ann Rheum Dis, May 1, 1999; 58(5): 291 - 296.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
O Meyer, B Combe, A Elias, K Benali, J Clot, J Sany, and J F Eliaou
Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage
Ann Rheum Dis, November 1, 1997; 56(11): 682 - 685.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.